Projects per year
Collaborations and top research areas from the last five years
Profiles
-
Jaap Akkerdaas
- Experimental Immunology - Research Associate
- Affiliatie UvA
- AII - Immunology - Research Associate
- APH - Personalized Medicine - Research Associate
- APH - Global Health - Research Associate
Person: Academic
-
Derk Amsen
- Experimental Immunology - Other Academic Staff
- Landsteiner Laboratory - Full Professor, Research Associate
- Affiliatie UvA
- AII - Immunology - Research Associate
Person: Academic
-
Optimizing combination treatment of targeted agents and T-cell engagers in CLL, a metabolic approach. EHA Junior Research Grant 2024.
Simon Molas, H. (Principal investigator)
01/01/2025 → …
Project: Research
-
Exploit altered lipid metabolism to improve T-cell function in chronic lymphocytic leukemia. CCA grant 2023.
Simon Molas, H. (Principal investigator)
01/03/2024 → 28/02/2026
Project: Research
-
Towards a novel therapy for Multiple Myeloma by identification of sensitizers for BCL-2 family inhibitors
Spaargaren, M. (Principal investigator), Groen, R. (CoPI), Pals, S. (CoPI), Guikema, J. (CoPI) & Eldering, E. (CoPI)
01/10/2022 → 30/09/2026
Project: Research
Research output
-
Cholesterol homeostasis and lipid raft dynamics at the basis of tumor-induced immune dysfunction in chronic lymphocytic leukemia
Jacobs, C. F., Peters, F. S., Camerini, E., Cretenet, G., Rietveld, J., Schomakers, B. V., van Weeghel, M., Hahn, N., Verberk, S. G. S., van den Bossche, J., Langeveld, M., Kleijwegt, F., Eldering, E., Zelcer, N., Kater, A. P. & Simon-Molas, H., 2025, (E-pub ahead of print) In: Cellular & molecular immunology. 5932.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia
Brown, J. R., Seymour, J. F., Jurczak, W., Aw, A., Wach, M., Illes, A., Tedeschi, A., Owen, C., Skarbnik, A., Lysak, D., Eom, K.-S., Šimkovič, M., Pavlovsky, M. A., Kater, A. P., Eichhorst, B., Miller, K., Munugalavadla, V., Yu, T., de Borja, M. & AMPLIFY investigators, 20 Feb 2025, In: The New England journal of medicine. 392, 8, p. 748-762 15 p.Research output: Contribution to journal › Article › Academic › peer-review
1 Citation (Scopus) -
Impact of COVID-19 disease and vaccination on dermatological immune-mediated inflammatory diseases atopic dermatitis, psoriasis, and vitiligo: a Target2B! substudy
van Buchem-Post, N. F., Ouwerkerk, W., Stalman, E. W., van Dam, K. P. J., Wieske, L., Bekkenk, M. W., Wolkerstorfer, A., Spuls, P., Musters, A. H., Bosma, A. L., Hijnen, D.-J., Eftimov, F., Luiten, R. M. & T2B! immunity against SARS-CoV-2 study group, Apr 2025, In: Journal of dermatology. 52, 4, p. 624-633 10 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile
Activities
- 1 Educational contribution
-
T-cell metabolism in Master's course ‘Cutting edge Immunology: from Chemistry to Metabolism’, LUMC.
Simon Molas, H. (Participant)
2022 → …Activity: Educational contribution / Supervising student theses, products › Educational contribution › Educational
Prizes
Press/Media
-
Alexandra Cloherty is the FameLab Netherlands Winner 2021
01/06/2021
1 item of Media coverage
Press/Media: Press / Media